Simon Kohl Tune in to explore the intersection of biology and machine learning, and how it’s shaping the future of scientific innovation. Simon kohl making biology programmable at latent labs. previously i co led deepmind's protein design team, co developed alphafold2 and have built alphafold2's widely used uncertainty prediction 'plddt'.
Making Biology Programmable Radical Ventures In this episode of nothing ventured, host aarish shah welcomes simon kohl, founder of latent labs, a startup at the forefront of generative models for computational protein design. As co founder and ceo of latent labs, he’s advancing a vision where biology becomes programmable, and drugs can be designed with the precision and speed of semiconductor engineering. Simon kohl, founder and ceo of latent labs and previous co lead of deepmind’s protein design team, explores how latent x is transforming drug discovery by making biology programmable. “our mission is to make biology programmable, really bringing biology into the computational realm, where the reliance on biological, wet lab experiments will be reduced over time,” kohl.
Simon Kohl On Alphafold Latent Labs And Generative A I In Biology Simon kohl, founder and ceo of latent labs and previous co lead of deepmind’s protein design team, explores how latent x is transforming drug discovery by making biology programmable. “our mission is to make biology programmable, really bringing biology into the computational realm, where the reliance on biological, wet lab experiments will be reduced over time,” kohl. In this week's #radicalreads, simon kohl, founder and ceo of latent labs, explores how the recently launched latent x model is making biology programmable by enabling scientists to design. Driven by a desire to focus exclusively on protein design, kohl decided to establish latent labs, bringing his expertise and passion to the forefront of computational biology. At latent labs, kohl is advancing a vision where biology becomes programmable, and drugs can be designed with the precision and speed of semiconductor engineering. Latent labs, recently launched from stealth with a substantial $50 million funding, seeks to make biology programmable. the startup, led by former deepmind scientist simon kohl, intends to leverage ai to optimize and generate proteins, partnering primarily with biotech and pharmaceutical companies.
Comments are closed.